Patent holdings for IPC class A61K 31/065

Total number of patents in this class: 93

10-year publication summary

3
8
19
11
16
4
7
3
0
0
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Canopy Growth Corporation
212
7
QH Holdings (Oregon), Inc.
54
5
Aprofol AG
23
4
Groupe Santé Devonian Inc.
23
3
The Regents of the University of California
20494
2
Abbott Laboratories
2323
2
The Trustees of the University of Pennsylvania
4406
2
Deakin University
131
2
IP Science Limited
20
2
Kemin Industries, Inc.
365
2
Oy Granula AB Ltd
25
2
Sami Labs Limited
105
2
U.S. NUTRACEUTICALS, LLC d/b/a Valensa International
24
2
AstaReal Co., Ltd.
10
2
Immd Sp. zo.o
4
2
Vestlandets Innovasjonsselskap AS
46
2
Neurawell Therapeutics
8
2
Neurothera Labs Inc.
10
2
Merck Patent GmbH
5733
1
DSM IP Assets B.V.
5457
1
Other owners 44